Beta-2 Microglobulin
Also known as: B2M
What Does Beta-2 Microglobulin Measure?
Beta-2 Microglobulin (B2M) is a small protein found on the surface of nearly all nucleated cells in the body, where it forms part of the Major Histocompatibility Complex (MHC) class I molecule. This protein is continuously shed from cell surfaces into the bloodstream and filtered by the kidneys, making blood and urine levels a sensitive indicator of cellular turnover and kidney filtration capacity. The test measures the concentration of this protein in blood (serum), urine, or cerebrospinal fluid depending on what condition is being investigated.
Why Does Beta-2 Microglobulin Matter?
B2M is a versatile clinical marker used primarily in three contexts: kidney function assessment, blood cancer monitoring, and immune system evaluation. In kidney disease, elevated urine B2M signals damage to the proximal tubules, the kidney's filtering units, often before standard tests like creatinine show abnormalities. In blood cancers such as multiple myeloma, lymphoma, and leukemia, serum B2M levels directly reflect tumor burden and are used as a prognostic staging tool — higher levels generally indicate more advanced disease and worse outcomes. In HIV and other immune conditions, B2M rises with increased immune cell destruction, making it a useful marker of disease progression and treatment response.
Normal Ranges
Males
0.8–2.4 mg/L (serum); urine: <0.3 mg/g creatinine
Females
0.8–2.4 mg/L (serum); urine: <0.3 mg/g creatinine
Children
Varies by age; generally <2.7 mg/L in serum for children under 10, higher in infants
Causes of High Levels
- Multiple myeloma and other plasma cell disorders — malignant plasma cells shed large amounts of B2M
- Chronic kidney disease or acute kidney injury — reduced glomerular filtration leads to B2M accumulation in blood
- Lymphoma and leukemia — high lymphocyte or tumor cell turnover increases B2M production
- HIV/AIDS — ongoing immune activation and CD4 cell destruction elevate B2M levels
- Autoimmune diseases such as lupus (SLE) or rheumatoid arthritis — chronic inflammation drives immune cell activity
- Hemodialysis-related amyloidosis — long-term dialysis patients accumulate B2M deposits in joints and tissues
Causes of Low Levels
- Aggressive immunosuppressive therapy — reduces immune cell activity and B2M shedding
- Successful treatment of blood cancers — tumor burden reduction leads to normalized B2M levels
How to Improve Your Beta-2 Microglobulin
Diet
- Adopt a low-sodium, kidney-friendly diet (less than 2,300 mg sodium/day) to reduce kidney strain and support filtration
- Increase intake of anti-inflammatory foods such as berries, leafy greens, fatty fish, and olive oil to reduce immune activation
- Limit processed meats, red meat, and high-purine foods which increase metabolic waste and kidney workload
- Stay well-hydrated with 6–8 glasses of water daily to support kidney filtration and B2M clearance
- Reduce alcohol consumption, which impairs kidney function and promotes systemic inflammation
Supplements
- Omega-3 fatty acids (EPA+DHA, 2–4 g/day) to reduce systemic inflammation and support immune regulation
- Vitamin D3 (1,000–2,000 IU/day with physician guidance) — deficiency is common in kidney disease and cancer patients and worsens immune dysregulation
- Curcumin (500–1,000 mg/day of standardized extract) — has demonstrated anti-inflammatory and anti-myeloma properties in research settings
- Probiotics (multi-strain, 10–50 billion CFU/day) to support gut-immune axis and reduce systemic inflammatory load
- N-acetylcysteine (NAC, 600 mg twice daily) — antioxidant support for kidney tubular cells, consult physician before use
Related Biomarkers
Frequently Asked Questions
What does a high Beta-2 Microglobulin level mean?
A high B2M level most commonly indicates one of three things: kidney disease (where the kidneys cannot filter B2M properly), a blood cancer such as multiple myeloma or lymphoma (where high tumor cell activity releases excess B2M), or an active immune condition such as HIV or autoimmune disease. Your doctor will interpret the result alongside other tests and your symptoms to determine the cause. A single elevated value should always be confirmed and investigated further before drawing conclusions.
Is Beta-2 Microglobulin used to diagnose multiple myeloma?
B2M is not used alone to diagnose multiple myeloma, but it is a critical part of staging the disease once diagnosed. The International Staging System (ISS) for multiple myeloma classifies patients into Stage I (B2M <3.5 mg/L), Stage II (B2M 3.5–5.5 mg/L), or Stage III (B2M >5.5 mg/L). Higher stages are associated with greater tumor burden and shorter survival, making B2M a powerful prognostic tool that guides treatment intensity.
Can kidney disease cause high Beta-2 Microglobulin?
Yes, kidney disease is one of the most common causes of elevated serum B2M. Since B2M is normally filtered and broken down by the kidneys' proximal tubules, any condition that impairs kidney function — including chronic kidney disease (CKD), diabetic nephropathy, or acute kidney injury — causes B2M to accumulate in the blood. Importantly, elevated urine B2M (even with normal blood levels) can signal early proximal tubule damage before standard kidney tests like creatinine become abnormal, making it a sensitive early warning marker.